Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine
1 other identifier
observational
100
1 country
1
Brief Summary
Investigate the potential of tissue grafting that includes human mesenchymal stem cells in the repair and potential stabilization of the degenerative Lumbar disk and facet joint denovo and at the time of surgical reconstruction. Our hypothesis proposes that stabilization will help restore normal structure and function in the degenerative lumbar spine may decrease chronic low back pain associated with the biomechanical demise of the degenerative disk or facet and may improve the natural history of adjacent segment disease found after spinal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 16, 2015
CompletedFirst Posted
Study publicly available on registry
August 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedFebruary 15, 2017
February 1, 2017
5 years
March 16, 2015
February 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Numeric Pain Rating Scale (NPRS)
Screening to 24 months
Oswestry Disability Index (ODI)
Screening to 24 months
Secondary Outcomes (2)
SF-12 Health Survey
Screening to 24 months
EQ-5D Quality Adjusted Life Years
Screening to 24 months
Eligibility Criteria
Patients between the age of 18-85 years who presents problems of degenerative lumbar disk.
You may qualify if:
- Male or female subject, at least 18 years of age, who is unresponsive to conservative therapy and needs surgical reconstruction of the degenerative lumbar spine.
You may not qualify if:
- Females who are pregnant or nursing, or plan on becoming pregnant during the 1st year after the procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Trinity Stem Cell Institution
Odessa, Florida, 33556, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Farhan N Siddiqi, MD
Foundation For Spinal Research Education And Humanitarian Care
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2015
First Posted
August 20, 2015
Study Start
July 1, 2013
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
February 15, 2017
Record last verified: 2017-02